Patient Referrals and Treatment
| Characteristic | Overall N = 20,383 | Sequence 1 n = 7,001 | Sequence 2 n = 6,082 | Sequence 3 n = 7,300 |
|---|---|---|---|---|
| Referrals, No. (%) | ||||
| Bariatrics | 366 (1.8) | 122 (1.7) | 94 (1.5) | 150 (2.1) |
| Behavioral health | 448 (2.2) | 133 (1.9) | 248 (4.1) | 67 (0.9) |
| Dietician | 1,144 (5.6) | 407 (5.8) | 396 (6.5) | 341 (4.7) |
| Endocrinology | 1,070 (5.2) | 321 (4.6) | 356 (5.9) | 393 (5.4) |
| Health and wellness | 832 (4.1) | 239 (3.4) | 325 (5.3) | 268 (3.7) |
| Bariatric procedure performed, No. (%) | 68 (0.3) | 23 (0.3) | 23 (0.4) | 22 (0.3) |
| Prescriptions, No. (%) | ||||
| Bupropion-naltrexone (Contrave) | 44 (0.2) | 15 (0.2) | 16 (0.3) | 13 (0.2) |
| Phentermine (Pondin/Fastin) | 258 (1.3) | 94 (1.3) | 68 (1.1) | 96 (1.3) |
| Liraglutide (Saxenda) | 5 (<0.1) | 1 (<0.1) | 1 (<0.1) | 3 (<0.1) |
| Lisdexamfetamine (Vyvanse) | 14 (<0.1) | 6 (<0.1) | 3 (<0.1) | 5 (<0.1) |
| Orlistat (Xenical/alli) | 1 (<0.1) | 1 (<0.1) | 0 (0) | 0 (0) |
| Phentermine-topiramate (Qsymia) | 12 (<0.1) | 5 (<0.1) | 4 (<0.1) | 3 (<0.1) |